Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

NBIX Insider Trading (Neurocrine Biosciences)

Insider Ownership Percentage: 4.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $12,853,681.31

Neurocrine Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Neurocrine Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neurocrine Biosciences Share Price & Price History

Current Price: $98.40
Price Change: Price Decrease of -0.06 (-0.06%)
As of 06/30/2022 01:18 PM ET

This chart shows the closing price history over time for NBIX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

Neurocrine Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/27/2022Julie CookeInsiderSell754$100.00$75,400.0016,918View SEC Filing Icon  
5/9/2022Richard F. PopsDirectorSell15,000$76.30$1,144,500.0029,512View SEC Filing Icon  
4/25/2022Gary A. LyonsDirectorSell15,000$92.76$1,391,400.00208,697View SEC Filing Icon  
4/1/2022William H. RastetterDirectorSell10,728$94.93$1,018,409.0434,022View SEC Filing Icon  
3/22/2022Darin LippoldtInsiderSell8,455$95.05$803,647.75View SEC Filing Icon  
3/18/2022Darin LippoldtInsiderSell300$95.00$28,500.00View SEC Filing Icon  
2/7/2022David W. BoyerInsiderSell240$81.07$19,456.80View SEC Filing Icon  
2/7/2022Kevin Charles GormanCEOSell8,710$80.82$703,942.20View SEC Filing Icon  
2/7/2022Matt AbernethyCFOSell3,310$80.79$267,414.90View SEC Filing Icon  
1/24/2022Stephen A. SherwinDirectorSell15,000$74.43$1,116,450.00View SEC Filing Icon  
1/10/2022Eiry RobertsInsiderSell2,632$74.50$196,084.00View SEC Filing Icon  
1/5/2022Kyle GanoInsiderSell28,266$85.50$2,416,743.00View SEC Filing Icon  
12/1/2021Matt AbernethyCFOSell1,645$82.59$135,860.55View SEC Filing Icon  
10/7/2021Dimitri E. GrigoriadisInsiderSell8,000$104.81$838,480.00View SEC Filing Icon  
10/7/2021Gary A. LyonsDirectorSell5,000$105.06$525,300.00View SEC Filing Icon  
10/4/2021Julie CookeInsiderSell987$101.73$100,407.51View SEC Filing Icon  
8/16/2021Eric BenevichInsiderSell5,628$89.62$504,381.36View SEC Filing Icon  
7/27/2021Malcolm Lloyd-SmithInsiderSell16,709$93.80$1,567,304.2015,801View SEC Filing Icon  
6/10/2021Gary A. LyonsDirectorSell10,000$100.27$1,002,700.00View SEC Filing Icon  
2/10/2021Malcolm Lloyd-SmithInsiderSell1,700$119.96$203,932.0033,610View SEC Filing Icon  
2/8/2021Eiry RobertsInsiderSell2,363$116.78$275,951.1417,231View SEC Filing Icon  
2/8/2021Kevin Charles GormanCEOSell10,466$116.75$1,221,905.50443,249View SEC Filing Icon  
2/8/2021Matt AbernethyCFOSell2,910$116.82$339,946.2013,043View SEC Filing Icon  
2/5/2021Kevin Charles GormanCEOSell2,422$114.16$276,495.52443,249View SEC Filing Icon  
2/5/2021Malcolm Lloyd-SmithInsiderSell865$114.15$98,739.7529,675View SEC Filing Icon  
1/26/2021Malcolm Lloyd-SmithInsiderSell1,100$119.97$131,967.0033,013View SEC Filing Icon  
1/25/2021Gary A. LyonsDirectorSell1,600$120.03$192,048.00View SEC Filing Icon  
1/8/2021Eiry RobertsInsiderSell2,632$111.06$292,309.9215,845View SEC Filing Icon  
1/8/2021Kevin Charles GormanCEOSell308,250$110.22$33,975,315.00584,520View SEC Filing Icon  
12/1/2020Matt AbernethyCFOSell1,645$94.66$155,715.7011,494View SEC Filing Icon  
11/12/2020Eric BenevichInsiderSell2,257$90.71$204,732.4717,405View SEC Filing Icon  
11/12/2020Kevin Charles GormanCEOSell3,390$90.78$307,744.20441,071View SEC Filing Icon  
11/2/2020Eric BenevichInsiderSell20,595$96.53$1,988,035.3535,969View SEC Filing Icon  
10/2/2020Julie CookeInsiderSell987$95.26$94,021.629,549View SEC Filing Icon  
8/5/2020Eiry RobertsInsiderSell2,257$118.84$268,221.8811,446View SEC Filing Icon  
8/5/2020Kevin Charles GormanCEOSell3,390$118.91$403,104.90438,021View SEC Filing Icon  
7/9/2020Darin LippoldtInsiderSell1,657$136.02$225,385.1427,678View SEC Filing Icon  
6/23/2020Eiry RobertsInsiderSell5,000$130.00$650,000.0014,416View SEC Filing Icon  
5/18/2020Darin LippoldtInsiderSell5,000$120.00$600,000.0031,021View SEC Filing Icon  
5/12/2020Haig P BozigianInsiderSell61,555$114.94$7,075,131.70157,727View SEC Filing Icon  
5/7/2020Dimitri E. GrigoriadisInsiderSell8,682$105.44$915,430.08104,741View SEC Filing Icon  
5/7/2020Matt AbernethyCFOSell15,000$110.21$1,653,150.0020,953View SEC Filing Icon  
4/28/2020Matt AbernethyCFOSell1,741$102.49$178,435.095,953View SEC Filing Icon  
4/28/2020Stephen A. SherwinDirectorSell17,687$99.39$1,757,910.9329,861View SEC Filing Icon  
4/24/2020Eiry RobertsInsiderSell1,934$99.47$192,374.98View SEC Filing Icon  
4/24/2020Kevin Charles GormanCEOSell2,906$99.45$289,001.70434,971View SEC Filing Icon  
4/15/2020Eric BenevichInsiderSell8,632$94.65$817,018.80View SEC Filing Icon  
2/10/2020Malcolm Lloyd-SmithInsiderSell28,969$104.56$3,028,998.6423,200View SEC Filing Icon  
2/7/2020Eiry RobertsInsiderSell1,623$103.31$167,672.137,452View SEC Filing Icon  
2/7/2020Kevin Charles GormanCEOSell3,248$103.35$335,680.80432,357View SEC Filing Icon  
2/7/2020Matt AbernethyCFOSell2,030$103.35$209,800.505,701View SEC Filing Icon  
2/5/2020Kevin Charles GormanCEOSell5,449$103.09$561,737.41423,351View SEC Filing Icon  
2/5/2020Kyle GanoInsiderSell3,690$103.05$380,254.50View SEC Filing Icon  
1/8/2020Eiry RobertsInsiderSell2,632$111.11$292,441.52View SEC Filing Icon  
12/2/2019Matt AbernethyCFOSell1,645$116.33$191,362.85View SEC Filing Icon  
11/18/2019Dimitri E. GrigoriadisInsiderSell5,000$115.98$579,900.00113,408View SEC Filing Icon  
11/8/2019Darin LippoldtInsiderSell10,000$110.01$1,100,100.0026,728View SEC Filing Icon  
11/8/2019Gary A. LyonsDirectorSell5,000$110.00$550,000.00225,697View SEC Filing Icon  
11/1/2019Dimitri E. GrigoriadisInsiderSell10,188$100.34$1,022,263.92118,596View SEC Filing Icon  
11/1/2019Gary A. LyonsDirectorSell5,000$100.22$501,100.00230,697View SEC Filing Icon  
10/14/2019Malcolm Lloyd-SmithInsiderSell9,956$90.85$904,502.60View SEC Filing Icon  
10/2/2019Julie CookeInsiderSell987$88.56$87,408.72View SEC Filing Icon  
9/3/2019Darin LippoldtInsiderSell6,736$100.00$673,600.00View SEC Filing Icon  
8/27/2019Darin LippoldtInsiderSell3,264$100.05$326,563.2021,625View SEC Filing Icon  
8/23/2019Darin LippoldtInsiderSell1,664$100.09$166,549.7621,625View SEC Filing Icon  
8/8/2019Kevin Charles GormanCEOSell80,000$95.31$7,624,800.00468,508View SEC Filing Icon  
8/6/2019Kevin Charles GormanCEOSell50,911$95.15$4,844,181.65468,508View SEC Filing Icon  
7/30/2019Darin LippoldtInsiderSell15,831$92.13$1,458,510.03160,732View SEC Filing Icon  
7/30/2019Gary A. LyonsDirectorSell10,000$92.07$920,700.00235,697View SEC Filing Icon  
7/15/2019Eric BenevichInsiderSell5,835$87.44$510,212.4014,910View SEC Filing Icon  
7/11/2019Haig P BozigianInsiderSell7,220$87.63$632,688.60149,096View SEC Filing Icon  
See Full Table
1 Stock With Growth Potential
This could be one of the best stocks to consider during this bear market run.
Click for ticker & full details

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

93.21% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NBIX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Neurocrine Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/7/2022Teachers Retirement System of The State of Kentucky21,145$1.98M0.0%+47.9%0.022%Search for SEC Filing on Google Icon
6/2/2022Verition Fund Management LLC103,534$9.71M0.1%-55.9%0.108%Search for SEC Filing on Google Icon
6/2/2022Mirae Asset Global Investments Co. Ltd.38,442$3.61M0.0%-11.6%0.040%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC25,533$2.39M0.0%-10.0%0.027%Search for SEC Filing on Google Icon
5/23/2022Neuberger Berman Group LLC7,482$0.70M0.0%+65.0%0.008%Search for SEC Filing on Google Icon
5/20/2022International Biotechnology Trust PLC203,000$3.15M0.7%-27.5%0.212%Search for SEC Filing on Google Icon
5/20/2022The Manufacturers Life Insurance Company 99,911$9.34M0.0%-6.8%0.105%Search for SEC Filing on Google Icon
5/20/2022Toroso Investments LLC3,144$0.30M0.0%+14.7%0.003%Search for SEC Filing on Google Icon
5/19/2022Capital International Investors47,027$4.41M0.0%-18.3%0.049%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA50,626$4.75M0.0%-83.7%0.053%Search for SEC Filing on Google Icon
5/17/2022Walleye Capital LLC25,533$2.39M0.0%-10.0%0.027%Search for SEC Filing on Google Icon
5/17/2022Walleye Trading LLC6,519$0.61M0.0%+24.3%0.007%Search for SEC Filing on Google Icon
5/17/2022Weiss Multi Strategy Advisers LLC20,000$1.88M0.0%-41.4%0.021%Search for SEC Filing on Google Icon
5/17/2022Advisors Asset Management Inc.15,435$1.45M0.0%-18.1%0.016%Search for SEC Filing on Google Icon
5/17/2022Penn Capital Management Company LLC3,567$0.33M0.0%+24.0%0.004%Search for SEC Filing on Google Icon
5/17/2022Meiji Yasuda Asset Management Co Ltd.6,310$0.59M0.0%-1.9%0.007%Search for SEC Filing on Google Icon
5/17/2022Point72 Hong Kong Ltd6,951$0.65M0.0%+165.3%0.007%Search for SEC Filing on Google Icon
5/17/2022Polar Capital Holdings Plc759,287$71.18M0.3%+2,114.5%0.794%Search for SEC Filing on Google Icon
5/17/2022Eaton Vance Management1,456,048$136.50M0.2%-21.2%1.523%Search for SEC Filing on Google Icon
5/17/2022Ensign Peak Advisors Inc65,990$6.19M0.0%-8.2%0.069%Search for SEC Filing on Google Icon
5/17/2022First Republic Investment Management Inc.10,852$1.02M0.0%+62.9%0.011%Search for SEC Filing on Google Icon
5/17/2022Guggenheim Capital LLC57,282$5.37M0.0%-7.9%0.060%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System156,173$14.64M0.0%-5.7%0.163%Search for SEC Filing on Google Icon
5/16/2022Deerfield Management Company L.P. Series C1,657,800$155.42M3.5%+20.3%1.735%Search for SEC Filing on Google Icon
5/16/2022Brinker Capital Investments LLC33,474$3.14M0.0%+23.8%0.035%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP259,635$24.34M0.4%+103.4%0.272%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP389,408$36.51M0.0%N/A0.407%Search for SEC Filing on Google Icon
5/16/2022Echo Street Capital Management LLC5,536$0.52M0.0%-33.3%0.006%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP3,723$0.35M0.0%+35.5%0.004%Search for SEC Filing on Google Icon
5/16/2022Atria Wealth Solutions Inc.4,596$0.43M0.0%N/A0.005%Search for SEC Filing on Google Icon
5/16/2022Hood River Capital Management LLC180,557$16.93M0.6%+2.1%0.189%Search for SEC Filing on Google Icon
5/16/2022Hsbc Holdings PLC58,156$5.45M0.0%+9.0%0.061%Search for SEC Filing on Google Icon
5/13/2022Silverarc Capital Management LLC20,482$1.92M0.8%N/A0.021%Search for SEC Filing on Google Icon
5/13/2022Rhenman & Partners Asset Management AB105,000$9.84M1.0%-30.5%0.110%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC1,280,123$120.01M0.1%-10.1%1.339%Search for SEC Filing on Google Icon
5/13/2022Bellevue Group AG3,023,451$283.45M3.3%-4.9%3.163%Search for SEC Filing on Google Icon
5/13/2022Ontario Teachers Pension Plan Board4,786$0.45M0.0%N/A0.005%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp883,091$82.79M0.0%+1.0%0.924%Search for SEC Filing on Google Icon
5/13/2022Verition Fund Management LLC103,534$9.71M0.1%-55.9%0.108%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.520,849$48.83M0.0%+2.2%0.545%Search for SEC Filing on Google Icon
5/13/2022Edgestream Partners L.P.26,123$2.45M0.2%-43.3%0.027%Search for SEC Filing on Google Icon
5/13/2022Lazard Asset Management LLC791$74K0.0%-98.4%0.001%Search for SEC Filing on Google Icon
5/13/2022Utah Retirement Systems16,683$1.56M0.0%-1.8%0.017%Search for SEC Filing on Google Icon
5/13/2022Mariner LLC10,796$1.01M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/13/2022Nelson Van Denburg & Campbell Wealth Management Group LLC5,832$0.55M0.0%-35.0%0.006%Search for SEC Filing on Google Icon
5/13/2022Caisse DE Depot ET Placement DU Quebec24,769$2.32M0.0%+37.8%0.026%Search for SEC Filing on Google Icon
5/13/2022Arrowstreet Capital Limited Partnership96,283$9.03M0.0%-14.3%0.101%Search for SEC Filing on Google Icon
5/13/2022First Trust Advisors LP640,459$60.04M0.1%+7.3%0.670%Search for SEC Filing on Google Icon
5/13/2022Prudential Financial Inc.60,851$5.71M0.0%+178.0%0.064%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.33,110$3.10M0.0%-12.1%0.035%Search for SEC Filing on Google Icon
5/13/2022USS Investment Management Ltd8,386$0.79M0.0%-59.6%0.009%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.161,492$15.14M0.1%+0.2%0.169%Search for SEC Filing on Google Icon
5/13/2022Bridgewater Associates LP5,020$0.47M0.0%+98.7%0.005%Search for SEC Filing on Google Icon
5/13/2022Parkman Healthcare Partners LLC63,234$5.93M1.7%N/A0.066%Search for SEC Filing on Google Icon
5/13/2022Mackenzie Financial Corp29,896$2.80M0.0%+193.3%0.031%Search for SEC Filing on Google Icon
5/13/2022Covestor Ltd377$35K0.0%+431.0%0.000%Search for SEC Filing on Google Icon
5/13/2022Loomis Sayles & Co. L P2,033$0.19M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/13/2022Candriam Luxembourg S.C.A.300,207$28.14M0.2%-3.1%0.314%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.8,777,458$822.89M0.0%-0.1%9.183%Search for SEC Filing on Google Icon
5/13/2022Rothschild & Co. Asset Management US Inc.78,514$7.36M0.1%-22.5%0.082%Search for SEC Filing on Google Icon
5/13/2022Allianz Asset Management GmbH266,022$24.94M0.0%+33.8%0.278%Search for SEC Filing on Google Icon
5/13/2022Canada Pension Plan Investment Board3,900$0.37M0.0%-84.4%0.004%Search for SEC Filing on Google Icon
5/13/2022DSM Capital Partners LLC1,351,331$126.69M1.7%-4.0%1.414%Search for SEC Filing on Google Icon
5/13/2022Blair William & Co. IL10,530$0.99M0.0%-31.3%0.011%Search for SEC Filing on Google Icon
5/13/2022Vontobel Holding Ltd.40,095$3.71M0.0%+83.3%0.042%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP417,604$39.15M0.0%+39.1%0.437%Search for SEC Filing on Google Icon
5/12/2022Integral Health Asset Management LLC35,000$3.28M0.9%N/A0.037%Search for SEC Filing on Google Icon
5/12/2022BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp14,645$1.37M0.0%-11.8%0.015%Search for SEC Filing on Google Icon
5/12/2022Yousif Capital Management LLC52,027$4.88M0.1%+3.3%0.054%Search for SEC Filing on Google Icon
5/12/2022Great West Life Assurance Co. Can98,938$9.67M0.0%-5.9%0.104%Search for SEC Filing on Google Icon
5/12/2022APG Asset Management N.V.321,910$27.12M0.1%-0.2%0.337%Search for SEC Filing on Google Icon
5/12/2022Commonwealth of Pennsylvania Public School Empls Retrmt SYS34,768$3.26M0.0%+10.5%0.036%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers255,264$23.93M0.0%+0.1%0.267%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC65,509$6.14M0.0%+42.5%0.069%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC293$27K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/12/2022Bank of Montreal Can82,743$7.67M0.0%-25.3%0.087%Search for SEC Filing on Google Icon
5/12/2022Natixis Advisors L.P.60,349$5.66M0.0%+118.6%0.063%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.3,005$0.28M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/12/2022AlphaCrest Capital Management LLC17,400$1.63M0.1%-45.4%0.018%Search for SEC Filing on Google Icon
5/12/2022PNC Financial Services Group Inc.3,150$0.30M0.0%+27.7%0.003%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.61,805$5.79M0.0%-78.2%0.065%Search for SEC Filing on Google Icon
5/12/2022Mitsubishi UFJ Trust & Banking Corp84,038$7.88M0.0%-12.8%0.088%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.209,599$19.65M0.1%+302.4%0.219%Search for SEC Filing on Google Icon
5/12/2022Lisanti Capital Growth LLC42,210$3.96M0.4%N/A0.044%Search for SEC Filing on Google Icon
5/12/2022Oppenheimer & Co. Inc.12,122$1.14M0.0%-1.3%0.013%Search for SEC Filing on Google Icon
5/12/2022HighTower Advisors LLC5,745$0.54M0.0%+48.8%0.006%Search for SEC Filing on Google Icon
5/12/2022Blueshift Asset Management LLC2,654$0.25M0.0%-39.1%0.003%Search for SEC Filing on Google Icon
5/11/2022US Bancorp DE31,115$2.92M0.0%+44.1%0.033%Search for SEC Filing on Google Icon
5/11/2022American Century Companies Inc.795,848$74.61M0.1%+534.5%0.833%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp1,703,093$159.67M0.0%-8.5%1.782%Search for SEC Filing on Google Icon
5/11/2022Coldstream Capital Management Inc.2,232$0.21M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/11/2022Handelsbanken Fonder AB15,267$1.43M0.0%+50.2%0.016%Search for SEC Filing on Google Icon
5/11/2022Massachusetts Financial Services Co. MA217,099$20.35M0.0%+2.8%0.227%Search for SEC Filing on Google Icon
5/11/2022Raymond James & Associates79,746$7.48M0.0%+21.5%0.083%Search for SEC Filing on Google Icon
5/11/2022Twin Tree Management LP11,847$1.11M0.0%+324.0%0.012%Search for SEC Filing on Google Icon
5/11/2022NN Investment Partners Holdings N.V.14,377$1.35M0.0%-31.0%0.015%Search for SEC Filing on Google Icon
5/11/2022Skandinaviska Enskilda Banken AB publ 155,253$14.56M0.1%+1.1%0.162%Search for SEC Filing on Google Icon
5/11/2022WINTON GROUP Ltd36,507$3.42M0.2%-9.8%0.038%Search for SEC Filing on Google Icon
5/10/2022South Dakota Investment Council3,247$0.30M0.0%-83.8%0.003%Search for SEC Filing on Google Icon
5/10/2022Profund Advisors LLC15,578$1.46M0.1%-9.8%0.016%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Neurocrine Biosciences logo
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-118568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL - Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Read More on Neurocrine Biosciences

Today's Range

Now: $98.40
Low: $96.39
High: $98.42

50 Day Range

MA: $90.72
Low: $75.79
High: $99.93

52 Week Range

Now: $98.40
Low: $71.88
High: $108.01

Volume

4,660 shs

Average Volume

807,060 shs

Market Capitalization

$9.40 billion

P/E Ratio

136.75

Dividend Yield

N/A

Beta

0.7

Who are the company insiders with the largest holdings of Neurocrine Biosciences?

Neurocrine Biosciences' top insider shareholders include:
  1. Kevin Charles Gorman (CEO)
  2. Gary A Lyons (Director)
  3. Eric Benevich (Insider)
  4. William H Rastetter (Director)
  5. Malcolm Lloyd-Smith (Insider)
  6. Richard F Pops (Director)
  7. Darin Lippoldt (Insider)
  8. Eiry Roberts (Insider)
  9. Julie Cooke (Insider)
  10. Matt Abernethy (CFO)
  11. David W Boyer (Insider)
  12. Dimitri E Grigoriadis (Insider)
  13. Kyle Gano (Insider)
  14. Stephen A Sherwin (Director)
Learn More about top insider investors at Neurocrine Biosciences.

Who are the major institutional investors of Neurocrine Biosciences?

Neurocrine Biosciences' top institutional investors include:
  1. Vanguard Group Inc. — 9.18%
  2. Bellevue Group AG — 3.16%
  3. Bank of New York Mellon Corp — 1.78%
  4. Deerfield Management Company L.P. Series C — 1.73%
  5. Eaton Vance Management — 1.52%
  6. DSM Capital Partners LLC — 1.41%
Learn More about top institutional investors of Neurocrine Biosciences stock.

Which institutional investors are selling Neurocrine Biosciences stock?

During the previous quarter, NBIX stock was sold by these institutional investors:
  1. Eaton Vance Management
  2. Zurcher Kantonalbank Zurich Cantonalbank
  3. BNP Paribas Arbitrage SA
  4. Citigroup Inc.
  5. Bank of New York Mellon Corp
  6. Bellevue Group AG
  7. Renaissance Technologies LLC
  8. Verition Fund Management LLC
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
  1. Kevin Charles Gorman (CEO)
  2. Gary A Lyons (Director)
  3. Eric Benevich (Insider)
  4. William H Rastetter (Director)
  5. Malcolm Lloyd-Smith (Insider)
  6. Richard F Pops (Director)
  7. Darin Lippoldt (Insider)
  8. Eiry Roberts (Insider)
  9. Julie Cooke (Insider)
  10. Matt Abernethy (CFO)
  11. David W Boyer (Insider)
  12. Dimitri E Grigoriadis (Insider)
  13. Kyle Gano (Insider)
  14. Stephen A Sherwin (Director)
Learn More investors selling Neurocrine Biosciences stock.

Which institutional investors are buying Neurocrine Biosciences stock?

Within the previous quarter, NBIX stock was bought by institutional investors including:
  1. Polar Capital Holdings Plc
  2. American Century Companies Inc.
  3. Wellington Management Group LLP
  4. Deerfield Management Company L.P. Series C
  5. GW&K Investment Management LLC
  6. Congress Asset Management Co. MA
  7. Connor Clark & Lunn Investment Management Ltd.
  8. Rice Hall James & Associates LLC
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.